These benefits were most evident in patients with higher baseline PaCO 2 levels (≥ 60 mmHg) and did not reach statistical significance in those with PaCO 2 < 60 mmHg.
← all excerpts
High-Flow Nasal Cannula in Hypercapnic Respiratory Failure: An Updated Systematic Review and Meta-Analysis.
1
—
—